NCBiotech News

Asklepios BioPharmaceutical (AskBio), a gene therapy platform company based in Chapel Hill, has spun out its fourth company, Actus Therapeutics, to develop gene therapies for rare genetic diseases including Pompe disease and epilepsy.

Why is the U.S. Department of Defense Advanced Research Projects Agency (DARPA) interested in agriculture? 

North Carolina entrepreneurs looking to validate and advance their business startup ideas are being encouraged to apply now through May 14 for NC IDEA’s new “no strings attached” SEED Micro-Grant Pilot Program.

Morrisville-based Metabolon, a metabolomics company, will analyze biomarkers of wellness and disease in U.S. veterans through the Million Veteran Program (MVP) of the U.S. Department of Veterans Affairs.

Worldwide Clinical Trials of Morrisville has formed a strategic alliance with KinderPharm of Exton, Pa., to create what the two clinical research organizations (CROs) are calling the world’s first center of excellence for pediatric drug development and clinical research for the pharmaceutical industry.

Cambrex Corp., a contract manufacturer of small molecules and active pharmaceutical ingredients (APIs) for drug clinical trials, is expanding again in High Point to meet growing business demand for its services.

Grifols, a Spanish biotherapeutics company that employs some 2,500 people in North Carolina, donated more than 25 million international units (IU) of blood clotting factor in 2017, as part of an eight-year commitment to changing the lives of people with hemophilia in 47 countries who have limited access to treatment.

​​​​​​​Good timing had a lot to do with the success of FoodLogiQ, the Durham-based software as a service (SaaS) provider of food traceability, safety and supply chain transparency, says co-founder Andrew Kennedy.

Camras Vision, an NCBiotech portfolio company developing a new medical device for treating glaucoma, has closed on $5.7M in equity funding in a Series A round.

Camras Vision, developer of a new medical device for treating glaucoma, won the Emerging Company Award at SEBIO’s 19th Annual Investor and Partnering Forum in Pinehurst. The honor came a few days before the company expects to close on $5 million in Series A financing.

Biovet S.A. Laboratories, a Spanish animal-nutrition company, has established a small office in Research Triangle Park to better serve the North American market.

Two North Carolina medical technology companies are among the six chosen to pitch their wares next Monday, April 9, during the inaugural Southeast Region Pitch Event at the North Carolina Biotechnology Center.

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy and Fast Track designations to Fennec Pharma’s drug designed to protect the hearing of children undergoing chemotherapy.

Two years after launching its U.S. subsidiary MP Pharma Services in Research Triangle Park, MedPharm has expanded its workforce and invested nearly $1M in new technology at the R&D facility. The U.K.-based company provides performance testing of topical and transdermal drug formulations and other contract services.

“How do we take advantage of this new world of biotechnology” affecting agriculture, asked Ann Bartuska, Ph.D., vice president of Land, Water, and Nature with Resources for the Future at the 2018 AgBiotech Summit. “There are a lot of opportunities in emerging technologies we have yet to capitalize on.”